ArticleEuropean journal of medical research2025
The association between the systemic inflammation response index and overactive bladder: a cross-sectional study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOveractive bladder (OAB) is an intricate disorder with an unclear pathophysiological relationship with inflammation. This study employs the Systemic Inflammation Response Index (SIRI) as a quantitative measure of systemic inflammatory status and explores its association with both the risk and severity of OAB, as assessed by the Overactive Bladder Symptom Score (OABSS).
methodsPopulation data from the National Health and Nutrition Examination Survey (NHANES) in 2005-2020 were extracted. Weighted logistic regression and weighted linear regression models were utilized to examine the relation of SIRI to OAB risk and OABSS. The possible nonlinear relation of SIRI to clinical outcomes was examined via restricted cubic spline (RCS) models. In addition, subgroup analyses and interaction tests helped to explore the consistency of these associations across subpopulations.
results23,915 individuals were encompassed for our analysis. 9011 (21%) were diagnosed with OAB. Both weighted linear and logistic regression analyses demonstrated a significant link of SIRI to OAB risk and symptom severity (fully adjusted model: β = 0.143, 95% CI 0.086-0.200, P < 0.001; OR = 1.268, 95% CI 1.122-1.413, P < 0.001). The RCS model showed a significant nonlinear relation of SIRI to clinical outcomes. Subgroup analyses further demonstrated the consistency of these associations across various subgroups.
conclusionsSIRI is a significant risk factor for OAB, and higher SIRI levels are strongly related to heightened OAB symptom severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.